Pharmaceutical companies are pushing to disrupt the recently passed Medicare Drug Price Negotiation Program. Learn how AARP is fighting to protect it.

FDA requires updated warning about rare heart risk with COVID shots Cases of myocarditis are more severe and more common after a COVID infection than after receiving the COVID vaccine, health ...

The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and ...

Mike Davis previously worked as clinical team leader at the FDA’s Division of Psychiatry before serving as chief medical officer for Usona Institute, a research organization advancing psychedelic ...

Jacqueline Corrigan-Curay, the top FDA drug regulator, acknowledged that much is still in flux at the agency and introduced a new deputy.

If the FDA charged food companies user fees it could strengthen its oversight of food safety, according to a recent study. The study, “Advancing the FDA’s ...

Corrigan-Curay has been with the FDA for more than eight years and assumed the acting CDER director role earlier this year after the center's former director, Patrizia Cavazzoni, M.D., stepped ...

The top drug regulator at the FDA is retiring in July, as departures of senior leaders mount.

The FDA is losing another top regulator amid the ongoing exodus of agency leaders and staffers under the Trump administration. Jacqueline Corrigan-Curay, the acting head of the Center for Drug ...

Top drug official at FDA reportedly set to exit next month Jacqueline Corrigan-Curay, who serves as acting head of the powerful CDER office, will leave after nearly a decade at the agency.

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

The Food and Drug Administration approved a new, highly effective HIV-prevention medication. The drug nearly eliminated HIV’s spread among people given an injection twice a year in clinical ...